Search cutoffs
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Current report (Form 8-K) · Jun 11, 2026 · Multiple disclosures including leadership change and acquisition or asset sale
TELA Bio, Inc.
7
Leadership change
Jun 11, 2026
| Form type | Current report (Form 8-K) |
| Event summary | Multiple disclosures including leadership change and acquisition or asset sale |
| Primary topic | Leadership change |
| About this form | Public companies file this within four business days when something important happens that investors should know about, before the next quarterly report. |
| Why this was filed | TELA Bio, Inc. filed this to disclose a change in directors or executive officers: appointments, departures, or role changes that can signal a strategic shift. |
| Labor angle | Watch for Item 2.05 (restructuring or severance), Item 5.02 (leadership changes), and Item 1.01 (major contracts that can precede workforce shifts). |
| Period of report | Jun 9, 2026 |
| Accession number | 0001104659-26-072931 |
| Reported items | Entered a material definitive agreement, Terminated a material definitive agreement, Completed an acquisition or asset sale, Released results of operations or financial condition, Created a direct financial obligation, Director or executive officer departure or appointment, Item 5.07, Financial statements and exhibits See Analysis tab for workforce implications |
